Kyowa Kirin Co., Ltd. (KYKOF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 14.10 means the share price is 14.10 times one year of earnings per share; the S&P 500 usually sits near 20-25.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerKyowa Kirin Co., Ltd. (KYKOF) trades at $15.80. Kyowa Kirin Co., Ltd. (KYKOF) is a global specialty pharmaceutical company focused on research, development, manufacturing, and marketing of prescription pharmaceuticals.
Price as of Sep 11, 2026 · Last analyzed: Sep 9, 2026Kyowa Kirin Co., Ltd. (KYKOF) is a global specialty pharmaceutical company focused on research, development, manufacturing, and marketing of prescription pharmaceuticals. A key area for Kyowa Kirin is likely in the therapeutic areas of nephrology, oncology, and immunology, given industry trends. A potential strength lies in their focus on innovative antibody technologies. However, as an OTC Other stock, KYKOF may present liquidity risks compared to exchange-listed equities. Investors should closely monitor the company's pipeline progress and any regulatory developments impacting their key products.
Analyst Coverage for KYKOF: KYKOF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KYKOF against sector peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
KYKOF: 2/2 scored disciplines lean bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Kyowa Kirin Co., Ltd. Company Overview
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
KYKOF Revenue & Earnings Trend
In Q2 FY2026, KYKOF generated $144.11B in top-line revenue, marking a sequential increase of 20.9%. The company recorded net income of $18.45B, with diluted EPS of $35.52. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in its sector. Across the four most recent quarters, KYKOF averaged $38.72 in diluted EPS.
KYKOF Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | ¥144.11B | ¥18.45B | ¥35.52 |
| Q1 FY2026 | ¥119.21B | ¥12.11B | ¥22.37 |
| Q4 FY2025 | ¥146.11B | ¥34.27B | ¥65.46 |
| Q3 FY2025 | ¥120.50B | ¥16.51B | ¥31.54 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Reported in JPY
KYKOF Latest News
No recent news available for KYKOF.
KYKOF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for KYKOF.
Price Targets
Wall Street price target analysis for KYKOF.
KYKOF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for KYKOF; grades run from A+ (80-100) to F (below 30).
KYKOF OTC Market Information
KYKOF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
Common Questions About KYKOF
Is KYKOF a good stock?
Stock Expert AI does not rate KYKOF buy, sell or hold. Kyowa Kirin Co., Ltd. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the key factors to evaluate for KYKOF?
Evaluate KYKOF on fundamentals, analyst consensus, and risk factors. P/E: 14.10x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does KYKOF data refresh on this page?
KYKOF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven KYKOF's recent stock price performance?
Kyowa Kirin Co., Ltd. (KYKOF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KYKOF overvalued or undervalued right now?
Kyowa Kirin Co., Ltd. (KYKOF) trades at 14.10x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of KYKOF?
Yes, most major brokerages offer fractional shares of Kyowa Kirin Co., Ltd. (KYKOF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track KYKOF's earnings and financial reports?
Kyowa Kirin Co., Ltd. (KYKOF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for KYKOF earnings announcements.
What should investors new to KYKOF understand first?
Kyowa Kirin Co., Ltd. (KYKOF) is worth researching across volatility, fundamentals, and industry context. The P/E ratio is 14.10x (value-oriented valuation). Start with the Company Overview and MoonshotScore tabs for a structured introduction.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.